Highlights

[TIGER] YoY Annualized Quarter Result on 2014-12-31 [#2]

Stock [TIGER]: TIGER SYNERGY BHD
Announcement Date 26-Feb-2015
Admission Sponsor -
Sponsor -
Financial Year 30-Jun-2015
Quarter 31-Dec-2014  [#2]
Profit Trend QoQ -     36.72%    YoY -     -177.34%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
Revenue 10,756 9,170 13,202 29,738 9,576 49,110 27,436 -13.40%
  YoY % 17.30% -30.54% -55.61% 210.55% -80.50% 79.00% -
  Horiz. % 39.20% 33.42% 48.12% 108.39% 34.90% 179.00% 100.00%
PBT 440 -936 -1,022 -1,754 2,876 2,088 3,940 -28.59%
  YoY % 147.01% 8.41% 41.73% -160.99% 37.74% -47.01% -
  Horiz. % 11.17% -23.76% -25.94% -44.52% 72.99% 52.99% 100.00%
Tax 176 0 0 0 -608 -238 -2,618 -
  YoY % 0.00% 0.00% 0.00% 0.00% -155.46% 90.91% -
  Horiz. % -6.72% -0.00% -0.00% -0.00% 23.22% 9.09% 100.00%
NP 616 -936 -1,022 -1,754 2,268 1,850 1,322 -11.07%
  YoY % 165.81% 8.41% 41.73% -177.34% 22.59% 39.94% -
  Horiz. % 46.60% -70.80% -77.31% -132.68% 171.56% 139.94% 100.00%
NP to SH 616 -936 -1,022 -1,754 2,268 1,850 1,322 -11.07%
  YoY % 165.81% 8.41% 41.73% -177.34% 22.59% 39.94% -
  Horiz. % 46.60% -70.80% -77.31% -132.68% 171.56% 139.94% 100.00%
Tax Rate -40.00 % - % - % - % 21.14 % 11.40 % 66.45 % -
  YoY % 0.00% 0.00% 0.00% 0.00% 85.44% -82.84% -
  Horiz. % -60.20% 0.00% 0.00% 0.00% 31.81% 17.16% 100.00%
Total Cost 10,140 10,106 14,224 31,492 7,308 47,260 26,114 -13.53%
  YoY % 0.34% -28.95% -54.83% 330.93% -84.54% 80.98% -
  Horiz. % 38.83% 38.70% 54.47% 120.59% 27.98% 180.98% 100.00%
Net Worth 231,304 208,590 187,366 175,399 166,319 70,916 46,658 27.88%
  YoY % 10.89% 11.33% 6.82% 5.46% 134.53% 51.99% -
  Horiz. % 495.74% 447.05% 401.57% 375.92% 356.46% 151.99% 100.00%
Dividend
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
Net Worth 231,304 208,590 187,366 175,399 166,319 70,916 46,658 27.88%
  YoY % 10.89% 11.33% 6.82% 5.46% 134.53% 51.99% -
  Horiz. % 495.74% 447.05% 401.57% 375.92% 356.46% 151.99% 100.00%
NOSH 1,652,178 1,390,600 851,666 797,272 755,999 308,333 194,411 38.92%
  YoY % 18.81% 63.28% 6.82% 5.46% 145.19% 58.60% -
  Horiz. % 849.83% 715.29% 438.07% 410.09% 388.87% 158.60% 100.00%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
NP Margin 5.73 % -10.21 % -7.74 % -5.90 % 23.68 % 3.77 % 4.82 % 2.69%
  YoY % 156.12% -31.91% -31.19% -124.92% 528.12% -21.78% -
  Horiz. % 118.88% -211.83% -160.58% -122.41% 491.29% 78.22% 100.00%
ROE 0.27 % -0.45 % -0.55 % -1.00 % 1.36 % 2.61 % 2.83 % -30.30%
  YoY % 160.00% 18.18% 45.00% -173.53% -47.89% -7.77% -
  Horiz. % 9.54% -15.90% -19.43% -35.34% 48.06% 92.23% 100.00%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
RPS 0.65 0.66 1.55 3.73 1.27 15.93 14.11 -37.67%
  YoY % -1.52% -57.42% -58.45% 193.70% -92.03% 12.90% -
  Horiz. % 4.61% 4.68% 10.99% 26.44% 9.00% 112.90% 100.00%
EPS 0.04 -0.06 0.12 -0.22 0.30 0.60 0.68 -35.29%
  YoY % 166.67% -150.00% 154.55% -173.33% -50.00% -11.76% -
  Horiz. % 5.88% -8.82% 17.65% -32.35% 44.12% 88.24% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1400 0.1500 0.2200 0.2200 0.2200 0.2300 0.2400 -7.95%
  YoY % -6.67% -31.82% 0.00% 0.00% -4.35% -4.17% -
  Horiz. % 58.33% 62.50% 91.67% 91.67% 91.67% 95.83% 100.00%
Adjusted Per Share Value based on latest NOSH - 1,468,640
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
RPS 0.73 0.62 0.90 2.02 0.65 3.34 1.87 -13.45%
  YoY % 17.74% -31.11% -55.45% 210.77% -80.54% 78.61% -
  Horiz. % 39.04% 33.16% 48.13% 108.02% 34.76% 178.61% 100.00%
EPS 0.04 -0.06 -0.07 -0.12 0.15 0.13 0.09 -11.71%
  YoY % 166.67% 14.29% 41.67% -180.00% 15.38% 44.44% -
  Horiz. % 44.44% -66.67% -77.78% -133.33% 166.67% 144.44% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1575 0.1420 0.1276 0.1194 0.1132 0.0483 0.0318 27.86%
  YoY % 10.92% 11.29% 6.87% 5.48% 134.37% 51.89% -
  Horiz. % 495.28% 446.54% 401.26% 375.47% 355.97% 151.89% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
Date 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 29/06/12 30/06/11 -
Price 0.0400 0.0450 0.0900 0.1300 0.1400 0.1400 0.1400 -
P/RPS 6.14 6.82 5.81 3.49 11.05 0.88 0.99 32.36%
  YoY % -9.97% 17.38% 66.48% -68.42% 1,155.68% -11.11% -
  Horiz. % 620.20% 688.89% 586.87% 352.53% 1,116.16% 88.89% 100.00%
P/EPS 107.28 -66.86 -75.00 -59.09 46.67 23.33 20.59 28.86%
  YoY % 260.45% 10.85% -26.93% -226.61% 100.04% 13.31% -
  Horiz. % 521.03% -324.72% -364.25% -286.98% 226.66% 113.31% 100.00%
EY 0.93 -1.50 -1.33 -1.69 2.14 4.29 4.86 -22.43%
  YoY % 162.00% -12.78% 21.30% -178.97% -50.12% -11.73% -
  Horiz. % 19.14% -30.86% -27.37% -34.77% 44.03% 88.27% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.29 0.30 0.41 0.59 0.64 0.61 0.58 -10.10%
  YoY % -3.33% -26.83% -30.51% -7.81% 4.92% 5.17% -
  Horiz. % 50.00% 51.72% 70.69% 101.72% 110.34% 105.17% 100.00%
Price Multiplier on Announcement Date
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 30/06/12 30/06/11 CAGR
Date 27/02/18 - 26/02/16 26/02/15 26/02/14 29/08/12 24/08/11 -
Price 0.0450 0.0400 0.0500 0.1300 0.1500 0.1300 0.1300 -
P/RPS 6.91 6.07 3.23 3.49 11.84 0.82 0.92 36.31%
  YoY % 13.84% 87.93% -7.45% -70.52% 1,343.90% -10.87% -
  Horiz. % 751.09% 659.78% 351.09% 379.35% 1,286.96% 89.13% 100.00%
P/EPS 120.69 -59.43 -41.67 -59.09 50.00 21.67 19.12 32.72%
  YoY % 303.08% -42.62% 29.48% -218.18% 130.73% 13.34% -
  Horiz. % 631.22% -310.83% -217.94% -309.05% 261.51% 113.34% 100.00%
EY 0.83 -1.68 -2.40 -1.69 2.00 4.62 5.23 -24.63%
  YoY % 149.40% 30.00% -42.01% -184.50% -56.71% -11.66% -
  Horiz. % 15.87% -32.12% -45.89% -32.31% 38.24% 88.34% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.32 0.27 0.23 0.59 0.68 0.57 0.54 -7.72%
  YoY % 18.52% 17.39% -61.02% -13.24% 19.30% 5.56% -
  Horiz. % 59.26% 50.00% 42.59% 109.26% 125.93% 105.56% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

554  214  591  1092 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.375+0.095 
 VC 0.055+0.005 
 KANGER 0.1750.00 
 MAHSING 1.03+0.05 
 LUSTER 0.175+0.005 
 MLAB 0.020.00 
 AT 0.085+0.005 
 VIVOCOM 0.0450.00 
 SUPERMX 9.75+0.54 
 ESCERAM 0.640.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. LION IN THE DEN SLEEPING, WAITING TO POUNCE !!! Bursa Master
2. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
3. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
4. [Humbled Investor] Careplus - Actual performance that exceeded market expectation HumbledInvestor
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. New Glove Catalyst-Hong Kong battling potentially deadly superbug Van Gogh of Financial
7. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS